Skip to main content

ADVERTISEMENT

Alberta Cifarelli, MD

Original Contribution
06/09/2009
ABSTRACT: Objective. We sought to evaluate the short- and long-term outcomes of Amplatzer Multi-Fenestrated Septal Occluder Cribriform (AMF) device use in the percutaneous closure of patent foramen ovale (PFO) associated with atrial septal...
ABSTRACT: Objective. We sought to evaluate the short- and long-term outcomes of Amplatzer Multi-Fenestrated Septal Occluder Cribriform (AMF) device use in the percutaneous closure of patent foramen ovale (PFO) associated with atrial septal...
ABSTRACT: Objective. We sought...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
10/02/2012
Abstract: Objectives. To evaluate the short- and mid-term clinical and echocardiographic outcome of  HELEX Septal Occluder (HSO) implantation in patients with patent foramen ovale (PFO) and atrial septal aneurysm (ASA). Background....
Abstract: Objectives. To evaluate the short- and mid-term clinical and echocardiographic outcome of  HELEX Septal Occluder (HSO) implantation in patients with patent foramen ovale (PFO) and atrial septal aneurysm (ASA). Background....
Abstract: Objectives. To...
10/02/2012
Journal of Invasive Cardiology
Original Contribution
11/01/2021
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues evaluate the short- and long-term clinical and echocardiographic outcomes of the percutaneous closure of the patent foramen ovale (PFO) with an atrial septal aneurysm (ASA) using 2 different devices.
Dr. Musto and colleagues...
11/01/2021
Journal of Invasive Cardiology